Arcturus Therapeutics Holdings (ARCT) EBITDA Margin (2018 - 2026)
Arcturus Therapeutics Holdings' EBITDA Margin was -843.02% in Q2 2026, down 804.80 percentage points from -38.22% a year earlier but up 526.75 percentage points from the prior quarter.
Arcturus Therapeutics Holdings (ARCT) EBITDA Margin (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arcturus Therapeutics Holdings' EBITDA Margin was -338.86% through Jun 30, 2026, down 282.15 percentage points year-over-year; for FY2025, it was -89.28%, down 28.79 percentage points from FY2024.
- EBITDA Margin has now declined for three consecutive years, though with a five-year change of +651.09 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -60.49% in FY2024 (-15.40 pp), -45.09% in FY2023 (-51.74 pp), 6.65% in FY2022 (+1638.27 pp) and -1631.62% in FY2021 (-891.25 pp).
- Quarterly EBITDA Margin has moved between -2196.18% (Q3 2021) and 76.10% (Q4 2022) over five years.
- Compared with a year earlier, EBITDA Margin has declined for four straight quarters, with an average year-over-year change of -314.29 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2022 (a gain of 2589.61 percentage points); the worst was Q1 2026 (a drop of 1315.23 percentage points).
- Per Business Quant data, ARCT's EBITDA Margin in the three quarters before Q2 2026 was -1369.77% (Q1 2026), -425.58% (Q4 2025) and -91.61% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Arcturus Therapeutics Holdings | 267.25 Mn | -551.34 Mn | - | -46.92% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -46.92% |
| Jun 30, 2026 | -843.02% |
| Mar 31, 2026 | -1,369.77% |
| Dec 31, 2025 | -425.58% |
| Sep 30, 2025 | -91.61% |
| Jun 30, 2025 | -38.22% |
| Mar 31, 2025 | -54.54% |
| Dec 31, 2024 | -143.09% |
| Sep 30, 2024 | -23.61% |
| Jun 30, 2024 | -40.57% |
| Mar 31, 2024 | -77.63% |
| Dec 31, 2023 | -56.44% |
| Sep 30, 2023 | -41.01% |
| Jun 30, 2023 | -519.76% |
| Mar 31, 2023 | 19.13% |
| Dec 31, 2022 | 76.10% |
| Sep 30, 2022 | -272.32% |
| Jun 30, 2022 | -80.05% |
| Mar 31, 2022 | -956.43% |
| Dec 31, 2021 | -644.55% |
Arcturus Therapeutics Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ARCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();